Chemical Industries (Far East) Past Earnings Performance
Past criteria checks 3/6
Chemical Industries (Far East)'s earnings have been declining at an average annual rate of -16.9%, while the Chemicals industry saw earnings declining at 20.4% annually. Revenues have been growing at an average rate of 8.8% per year. Chemical Industries (Far East)'s return on equity is 3.8%, and it has net margins of 7.1%.
Key information
-16.9%
Earnings growth rate
-16.9%
EPS growth rate
| Chemicals Industry Growth | 0.9% |
| Revenue growth rate | 8.8% |
| Return on equity | 3.8% |
| Net Margin | 7.1% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Solid Earnings May Not Tell The Whole Story For Chemical Industries (Far East) (SGX:C05)
Jul 19
Chemical Industries (Far East) (SGX:C05) Has Affirmed Its Dividend Of SGD0.015
Jul 18Little Excitement Around Chemical Industries (Far East) Limited's (SGX:C05) Earnings
Jun 25Chemical Industries (Far East) Limited's (SGX:C05) P/S Still Appears To Be Reasonable
Feb 20Returns On Capital At Chemical Industries (Far East) (SGX:C05) Have Stalled
May 05The Returns At Chemical Industries (Far East) (SGX:C05) Aren't Growing
Oct 12The Return Trends At Chemical Industries (Far East) (SGX:C05) Look Promising
May 11Be Wary Of Chemical Industries (Far East) (SGX:C05) And Its Returns On Capital
May 31What Can We Learn About Chemical Industries (Far East)'s (SGX:C05) CEO Compensation?
Feb 21Does Chemical Industries (Far East)'s (SGX:C05) Statutory Profit Adequately Reflect Its Underlying Profit?
Jan 14
Can Chemical Industries (Far East) (SGX:C05) Turn Things Around?
Dec 19Does Chemical Industries (Far East)'s (SGX:C05) CEO Salary Compare Well With Industry Peers?
Nov 22Revenue & Expenses Breakdown
How Chemical Industries (Far East) makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 73 | 5 | 11 | 0 |
| 31 Dec 23 | 80 | 3 | 12 | 0 |
| 30 Sep 23 | 88 | 1 | 12 | 0 |
| 30 Jun 23 | 94 | 2 | 12 | 0 |
| 31 Mar 23 | 100 | 4 | 12 | 0 |
| 31 Dec 22 | 100 | 7 | 13 | 0 |
| 30 Sep 22 | 101 | 10 | 15 | 0 |
| 30 Jun 22 | 93 | 8 | 14 | 0 |
| 31 Mar 22 | 85 | 7 | 14 | 0 |
| 31 Dec 21 | 76 | 3 | 13 | 0 |
| 30 Sep 21 | 67 | 0 | 12 | 0 |
| 30 Jun 21 | 65 | 3 | 12 | 0 |
| 31 Mar 21 | 63 | 6 | 12 | 0 |
| 31 Dec 20 | 62 | 5 | 12 | 0 |
| 30 Sep 20 | 62 | 5 | 12 | 0 |
| 30 Jun 20 | 62 | 4 | 11 | 0 |
| 31 Mar 20 | 62 | 3 | 11 | 0 |
| 31 Dec 19 | 63 | 7 | 11 | 0 |
| 30 Sep 19 | 64 | 11 | 10 | 0 |
| 30 Jun 19 | 67 | 11 | 10 | 0 |
| 31 Mar 19 | 69 | 11 | 10 | 0 |
| 31 Dec 18 | 71 | 11 | 10 | 0 |
| 30 Sep 18 | 73 | 10 | 10 | 0 |
| 30 Jun 18 | 72 | 10 | 10 | 0 |
| 31 Mar 18 | 71 | 9 | 10 | 0 |
| 31 Dec 17 | 69 | 8 | 10 | 0 |
| 30 Sep 17 | 66 | 7 | 10 | 0 |
| 30 Jun 17 | 62 | 8 | 10 | 0 |
| 31 Mar 17 | 58 | 9 | 11 | 0 |
| 31 Dec 16 | 58 | 9 | 12 | 0 |
| 30 Sep 16 | 57 | 9 | 14 | 0 |
| 30 Jun 16 | 68 | 11 | 14 | 0 |
| 31 Mar 16 | 78 | 13 | 14 | 0 |
| 31 Dec 15 | 83 | 13 | 13 | 0 |
| 30 Sep 15 | 87 | 13 | 11 | 0 |
| 30 Jun 15 | 87 | 10 | 11 | 0 |
| 31 Mar 15 | 87 | 8 | 10 | 0 |
| 31 Dec 14 | 89 | 10 | 10 | 0 |
| 30 Sep 14 | 92 | 11 | 10 | 0 |
| 30 Jun 14 | 96 | 11 | 10 | 0 |
| 31 Mar 14 | 100 | 10 | 10 | 0 |
| 31 Dec 13 | 101 | 6 | 10 | 0 |
Quality Earnings: C05 has a large one-off gain of SGD10.0M impacting its last 12 months of financial results to 31st March, 2024.
Growing Profit Margin: C05's current net profit margins (7.1%) are higher than last year (3.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: C05's earnings have declined by 16.9% per year over the past 5 years.
Accelerating Growth: C05's earnings growth over the past year (44.8%) exceeds its 5-year average (-16.9% per year).
Earnings vs Industry: C05 earnings growth over the past year (44.8%) exceeded the Chemicals industry 38.2%.
Return on Equity
High ROE: C05's Return on Equity (3.8%) is considered low.